BioAge Labs BIOA
NASDAQ BIOA
$9.17 -0.23 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026)

BioAge Labs' (BIOA) quarterly Other Non-Current Liabilities came in at $678000.0 in Q2 2026, up 527.78% year-over-year from $108000.0 in Q2 2025, and up 42.14% quarter-over-quarter from $477000.0 in Q1 2026.

Analysis

BioAge Labs (BIOA) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

BioAge Labs has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $678000.0 for Q2 2026.

  • In Q2 2026, Other Non-Current Liabilities rose 527.78% year-over-year to $678000.0; the TTM figure through Jun 2026 stood at $678000.0 (up 527.78% YoY), while the FY2025 annual figure was $370000.0, up 137.18% from the prior year.
  • Other Non-Current Liabilities came in at $678000.0 for Q2 2026 at BioAge Labs, up from $477000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $678000.0 in Q2 2026 to a low of $97000.0 in Q1 2025.
  • Average Other Non-Current Liabilities over 4 years is $319777.8, with a median of $229000.0 recorded in 2023.
  • Year-over-year, Other Non-Current Liabilities tumbled 75.53% in 2025 and surged 527.78% in 2026.
  • Over 4 years, Other Non-Current Liabilities stood at $229000.0 in 2023, then plunged by 31.88% to $156000.0 in 2024, then soared by 137.18% to $370000.0 in 2025, then soared by 83.24% to $678000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $678000.0 in Q2 2026, $477000.0 in Q1 2026, and $370000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioAge Labs 439.00 Mn 439.00 Mn -14.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 678,000.00
Mar 31, 2026 477,000.00
Dec 31, 2025 370,000.00
Sep 30, 2025 150,000.00
Jun 30, 2025 108,000.00
Mar 31, 2025 97,000.00
Dec 31, 2024 156,000.00
Sep 30, 2024 613,000.00
Dec 31, 2023 229,000.00